Genito-Urinary Drugs Global Market Report 2022

Mar 2022| TBR950D| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Pharmaceutical Drugs; Biologics
2) By Drug Type: Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
4) By Route Of Administration: Oral; Parenteral; Others
5) By Drug Classification: Branded Drugs; Generic Drugs
6) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Covering: Sanofi S.A.; GlaxosmithKline; AstraZeneca; AbbVie; Reckitt; Benckiser Group plc.; Astellas Pharma Inc.

Genito-Urinary Drugs Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global genito-urinary drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the genito-urinary drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Genito-Urinary Drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider genito-urinary drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The genito-urinary drugs market section of the report gives context. It compares the genito-urinary drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, genito-urinary drugs indicators comparison.

 

 

Frequently Asked Questions (FAQs)

Scope

Markets Covered:

  • By Type: Pharmaceutical Drugs; Biologics
  • By Drug Type: Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • By Route Of Administration: Oral; Parenteral; Others
  • By Drug Classification: Branded Drugs; Generic Drugs
  • By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Sanofi S.A.; GlaxosmithKline; AstraZeneca; AbbVie; Reckitt

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, genito-urinary drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Historic Market Growth, Value ($ Billion)
  • Table 2 : Forecast Market Growth, Value ($ Billion)
  • Table 3 : Global Genito-Urinary Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 4 : Global Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 5 : Global Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6 : Global Genito-Urinary Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7 : Global Genito-Urinary Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8 : Global Genito-Urinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9 : Global Genito-Urinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10 : Global Genito-Urinary Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11 : Global Genito-Urinary Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12 : Genito-Urinary Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Table 13 : Per Capita Average Genito-Urinary Drugs Market Expenditure, 2016-2026, Global
  • Table 14 : Asia-Pacific, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 15 : Asia-Pacific, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 16 : Asia-Pacific, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 17 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Table 18 : Asia-Pacific Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 19 : China Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 20 : China Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 21 : Australia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 22 : Australia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 23 : Hong Kong Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 24 : India Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 25 : India Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 26 : Indonesia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 27 : Indonesia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 28 : Japan Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 29 : Japan Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 30 : Malaysia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 31 : New Zealand Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 32 : Philippines Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 33 : Singapore Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 34 : South Korea Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 35 : Thailand Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 36 : Vietnam Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 37 : Western Europe, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 38 : Western Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 39 : Western Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 40 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Western Europe Countries
  • Table 41 : Western Europe Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 42 : Austria Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 43 : Belgium Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 44 : Denmark Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 45 : Finland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 46 : France Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 47 : France Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 48 : Germany Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 49 : Germany Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 50 : Ireland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 51 : Italy Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 52 : Netherlands Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 53 : Norway Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 54 : Portugal Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 55 : Spain Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 56 : Sweden Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 57 : Switzerland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 58 : UK Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 59 : UK Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 60 : Eastern Europe, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 61 : Eastern Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 62 : Eastern Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 63 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Table 64 : Eastern Europe Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 65 : Czech Republic Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 66 : Poland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 67 : Romania Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 68 : Russia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 69 : Russia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 70 : North America, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 71 : North America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 72 : North America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 73 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, North America Countries
  • Table 74 : North America Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 75 : Canada Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 76 : Mexico Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 77 : USA Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 78 : USA Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 79 : South America, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 80 : South America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 81 : South America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 82 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, South America Countries
  • Table 83 : South America Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 84 : Argentina Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 85 : Brazil Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 86 : Brazil Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 87 : Chile Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 88 : Colombia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 89 : Peru Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 90 : Venezuela Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 91 : Middle East, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 92 : Middle East, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 93 : Middle East, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 94 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Middle East Countries
  • Table 95 : Middle East Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 96 : Saudi Arabia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 97 : Israel Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 98 : Turkey Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 99 : UAE Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 100 : Africa, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 101 : Africa, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 102 : Africa, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 103 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Africa Countries
  • Table 104 : Africa Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 105 : Egypt Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 106 : Nigeria Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 107 : South Africa Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 108 : Sanofi S.A Financial Performance
  • Table 109 : GlaxosmithKline Financial Performance
  • Table 110 : AstraZeneca Financial Performance
  • Table 111 : AbbVie Financial Performance
  • Table 112 : Reckitt Financial Performance
  • Table 113 : Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Table 114 : Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 115 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 116 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Table 117 : Global Genito-Urinary Drugs Market In 2026- Growth Countries
  • Table 118 : Global Genito-Urinary Drugs Market In 2026- Growth Segments
  • Table 119 : Global Genito-Urinary Drugs Market In 2026- Growth Strategies
  • Figure 1 : Historic Market Growth, Value ($ Billion)
  • Figure 2 : Forecast Market Growth, Value ($ Billion)
  • Figure 3 : Global Genito-Urinary Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 4 : Global Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 5 : Global Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6 : Global Genito-Urinary Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7 : Global Genito-Urinary Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8 : Global Genito-Urinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9 : Global Genito-Urinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10 : Global Genito-Urinary Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11 : Global Genito-Urinary Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12 : Genito-Urinary Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Figure 13 : Per Capita Average Genito-Urinary Drugs Market Expenditure, 2016-2026, Global
  • Figure 14 : Asia-Pacific, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 15 : Asia-Pacific, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 16 : Asia-Pacific, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 17 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Figure 18 : Asia-Pacific Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 19 : China Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 20 : China Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 21 : Australia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 22 : Australia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 23 : Hong Kong Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 24 : India Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 25 : India Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 26 : Indonesia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 27 : Indonesia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 28 : Japan Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 29 : Japan Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 30 : Malaysia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 31 : New Zealand Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 32 : Philippines Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 33 : Singapore Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 34 : South Korea Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 35 : Thailand Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 36 : Vietnam Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 37 : Western Europe, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 38 : Western Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 39 : Western Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 40 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Western Europe Countries
  • Figure 41 : Western Europe Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 42 : Austria Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 43 : Belgium Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 44 : Denmark Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 45 : Finland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 46 : France Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 47 : France Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 48 : Germany Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 49 : Germany Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 50 : Ireland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 51 : Italy Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 52 : Netherlands Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 53 : Norway Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 54 : Portugal Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 55 : Spain Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 56 : Sweden Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 57 : Switzerland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 58 : UK Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 59 : UK Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 60 : Eastern Europe, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 61 : Eastern Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 62 : Eastern Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 63 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Figure 64 : Eastern Europe Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 65 : Czech Republic Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 66 : Poland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 67 : Romania Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 68 : Russia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 69 : Russia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 70 : North America, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 71 : North America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 72 : North America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 73 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, North America Countries
  • Figure 74 : North America Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 75 : Canada Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 76 : Mexico Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 77 : USA Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 78 : USA Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 79 : South America, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 80 : South America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 81 : South America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 82 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, South America Countries
  • Figure 83 : South America Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 84 : Argentina Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 85 : Brazil Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 86 : Brazil Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 87 : Chile Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 88 : Colombia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 89 : Peru Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 90 : Venezuela Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 91 : Middle East, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 92 : Middle East, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 93 : Middle East, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 94 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Middle East Countries
  • Figure 95 : Middle East Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 96 : Saudi Arabia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 97 : Israel Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 98 : Turkey Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 99 : UAE Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 100 : Africa, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 101 : Africa, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 102 : Africa, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 103 : Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Africa Countries
  • Figure 104 : Africa Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 105 : Egypt Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 106 : Nigeria Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 107 : South Africa Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 108 : Sanofi S.A Financial Performance
  • Figure 109 : GlaxosmithKline Financial Performance
  • Figure 110 : AstraZeneca Financial Performance
  • Figure 111 : AbbVie Financial Performance
  • Figure 112 : Reckitt Financial Performance
  • Figure 113 : Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Figure 114 : Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 115 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 116 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Figure 117 : Global Genito-Urinary Drugs Market In 2026- Growth Countries
  • Figure 118 : Global Genito-Urinary Drugs Market In 2026- Growth Segments
  • Figure 119 : Global Genito-Urinary Drugs Market In 2026- Growth Strategies

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Genito-Urinary Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • Date - Feb 2021
  • Code - TBR950C

Including: 1) By Type: Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By ...

Genito-Urinary Drugs Global Market Strategic Briefing 2020: Covid 19 Impact and Recovery

  • Date - Jun 2020
  • Code - TBR950B

Including: Hormonal Contraceptives; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Drugs For Erectile Dysfunction; Drugs For Benign Prostatic hypertrophy; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infertility; Diuretics

The global genito-urinary drugs market is expected to decline from $54.1 billion in 2019 to $53.7 billion in 2020 at a CAGR of -0.73%, this is due ...

Genito-Urinary Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

  • Date - May 2020
  • Code - TBR950A

Including: 1) By Type: Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: ...

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS